S-3ASR
As
filed with the Securities and Exchange Commission on September 18, 2006
Registration No. 333-
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM S-3
REGISTRATION STATEMENT
Under The Securities Act of 1933
GARTNER, INC.
(Exact name of Registrant as specified in its charter)
|
|
|
Delaware
(State or other jurisdiction of
incorporation or organization)
|
|
04-3099750
(I.R.S. Employer
Identification Number) |
P.O. Box 10212
56 Top Gallant Road
Stamford, CT 06902-7700
(293) 316-1111
(Address, including zip code, and telephone number, including area code, of Registrants principal executive offices)
Lewis G. Schwartz, Esq.
General Counsel
Gartner, Inc.
P.O. Box 10212
56 Top Gallant Road
Stamford, CT 06902-7700
(203) 316-1111
(Name, address, including zip code, and telephone number, including area code, of agent for service)
Copies to:
Larry W. Sonsini, Esq.
Robert Sanchez, Esq.
Adam M. Dinow, Esq.
Wilson Sonsini Goodrich & Rosati
Professional Corporation
650 Page Mill Road
Palo Alto, CA 94304
(650) 493-9300
Approximate date of commencement of proposed sale to the public: From time to time after the effective date of this Registration Statement.
If the only securities being registered on this Form are being offered pursuant to dividend or interest reinvestment plans, please check the following box: o
If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933, other
than securities offered only in connection with dividend or interest reinvestment plans, check the following
box: þ
If this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, please check the following box and list the
Securities Act registration statement number of the earlier effective registration statement for the same offering. o
If this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration
statement number of the earlier effective registration statement for the same offering. o
If this Form is a registration statement pursuant to General Instruction I.D. or a post-effective amendment thereto that shall become effective upon filing with the
Commission pursuant to Rule 462(e) under the Securities Act, check the following box. þ
If this Form is a post-effective amendment to a registration statement filed pursuant to General Instruction I.D. filed to register additional securities or additional
classes of securities pursuant to Rule 413(b) under the Securities Act, check the following box. o
CALCULATION OF REGISTRATION FEE
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Proposed |
|
|
Proposed Maximum |
|
|
|
|
|
Title of Each Class of Securities |
|
|
Amount to be |
|
|
Maximum Offering |
|
|
Aggregate |
|
|
Amount of |
|
|
to be Registered |
|
|
Registered |
|
|
Price Per Unit (1) |
|
|
Offering Price |
|
|
Registration Fee |
|
|
Common Stock, $0.0005 par value |
|
|
2,200,000 |
|
|
$15.66 |
|
|
$34,452,000 |
|
|
$3,687 |
|
|
|
|
|
(1) |
|
Estimated solely for the purpose of computing the amount of the registration fee pursuant to Rule 457(c) under the Securities Act of 1933, as amended based on the average of the
high and low prices of the Common Stock on the New York Stock
Exchange on September 14, 2006. |
PROSPECTUS
GARTNER
2,200,000 Shares
Common Stock
This prospectus relates to the resale of up to an aggregate of 2,200,000 shares of common
stock of Gartner, Inc. by the selling stockholders identified in this prospectus.
The selling stockholders identified in this prospectus may offer the shares from time to time
as each selling stockholder may determine through public or private transactions or through other
means described in the section of this prospectus entitled Plan of Distribution beginning on page
11. The registration of these shares for resale does not necessarily mean that the selling
stockholders will sell any of their shares.
We are not selling any securities under this prospectus and will not receive any of the
proceeds from the sale of the shares by the selling stockholders.
Our common stock is listed on the New York Stock Exchange under the symbol IT. The last
reported sale price of our common stock on September 14, 2006 was
$15.76 per share.
Investing in our common stock involves risks and uncertainties. See Risk Factors
beginning on page 3 of this prospectus and under similar headings in the other documents that are
incorporated in this prospectus by reference to read about factors you should consider before
buying shares of our common stock.
Neither the Securities and Exchange Commission nor any state securities commission has
approved or disapproved of these securities or passed upon the adequacy or accuracy of this
prospectus. Any representation to the contrary is a criminal offense.
The date
of this prospectus is September 18, 2006.
TABLE OF CONTENTS
FORWARD LOOKING STATEMENTS
This prospectus includes and incorporates by reference forward looking statements within the
meaning of the Private Securities Litigation Reform Act of 1995. These statements relate to
analyses and other information that are based on forecasts of future results and estimates of
amounts not yet determinable. These statements also relate to future prospects, developments and
business strategies. These forward looking statements are identified by their use of terms and
phrases such as anticipate, believe, could, estimate, expect, intend, may, plan,
predict, project, should, will and similar terms and phrases, including references to
assumptions. Such statements are based on current expectations, are inherently uncertain and are
subject to changing assumptions.
Such forward looking statements involve known and unknown risks, uncertainties and other
factors that may cause actual results to be materially different. Such factors include, but are
not limited to, the following: our ability to fully implement or develop our long term growth
strategy; our ability to expand or even retain our customer base; our ability to grow or even
sustain revenue from individual customers; our ability to attract and retain a professional staff
of research analysts and consultants upon whom we are dependent; our ability to achieve and
effectively manage growth; our ability to pay our debt obligations; our ability to achieve
continued customer renewals and achieve new contract value, backlog and deferred revenue growth in
light of competitive pressures; our ability to carry out our strategic initiatives and manage
associated costs; our ability to successfully compete with existing competitors and potential new
competitors; our ability to enforce or protect our intellectual property rights; additional risks
associated with international operations including foreign currency fluctuations; and the other
factors described under Risk Factors below and in documents incorporated herein by reference.
Additional information regarding these factors is contained in our Annual Report on Form 10-K for
the year ended December 31, 2005 and our Quarterly Reports on Form 10-Q for the quarters ended
March 31, 2006 and June 30, 2006.
If one or more of these risks or uncertainties materialize, or if underlying assumptions prove
incorrect, actual results may vary materially from those expected, estimated or projected. In
addition to other factors that affect our operating results and financial position, neither past
financial performance nor our expectations should be considered reliable indicators of future
performance. Investors should not use historical trends to anticipate results or trends in future
periods. Further, our stock price is subject to volatility. Any of the factors discussed above
could have an adverse impact on our stock price. In addition, failure of sales or income in any
quarter to meet the investment communitys expectations, as well as broader market trends, could
have an adverse impact on our stock price. We do not undertake an obligation to update such
forward looking statements or risk factors to reflect future events or circumstances.
-i-
PROSPECTUS SUMMARY
This summary may not contain all of the information that may be important to you. You should
read the entire prospectus, including the information set forth under the Risk Factors section
beginning on page 3 of this prospectus and the financial data and related notes included or
incorporated by reference herein, before making an investment decision. The terms Gartner, the
Company, we and us in this prospectus refer to Gartner, Inc. and its subsidiaries, unless the
context otherwise requires. Unless otherwise noted, all references in this prospectus to a number
or percentage of shares outstanding are based on 114,007,012 shares of our common stock outstanding
as of August 31, 2006.
General
Gartner, Inc. is a leading research and advisory firm that helps executives use technology to
build, guide and grow their enterprises. We offer independent and objective research and analysis
on the information technology, computer hardware, software, communications and related technology
industries (the IT industry). We provide comprehensive coverage of the IT industry to
approximately 10,000 client organizations, including approximately 400 Fortune 500 companies,
across 75 countries. Our client base consists primarily of chief information officers (CIOs) and
other senior IT and business executives from a wide variety of enterprises, government agencies and
the investment community.
The foundation for all Gartner products is our independent research on IT issues. The
findings from this research are delivered through our three customer channels, depending on a
clients specific business needs, preferences and objectives:
|
|
|
Researchprovides research content and advice for IT professionals, technology
companies and the investment community in the form of reports and briefings, as well as
peer networking services and membership programs designed specifically for CIOs and
other senior executives. |
|
|
|
|
Consultingconsists primarily of consulting, measurement engagements and strategic
advisory services (paid one-day analyst engagements), which provide assessments of
cost, performance, efficiency and quality focused on the IT industry. |
|
|
|
|
Eventsconsists of various symposia, conferences and exhibitions focused on the IT
industry. |
Since its founding in 1979, Gartner has established a leading brand in the IT research
marketplace based on the consistent quality and thoroughness of its analysis. Our products are
mission-critical tools in the IT decision-making process, as evidenced by our strong client
retention over time.
Our Solution
We are a leading research and advisory firm that helps executives use technology to build,
guide and grow their enterprises. We provide high quality independent and objective research and
analysis on the IT industry. Through our entire product portfolio, our global research community
provides provocative thought leadership and insight about technology acquisition and deployment to
CIOs, executives and other technology leaders.
With a base of 650 highly skilled research analysts, we create timely and relevant
technology-related research. We employ more analysts than any of our competitors, enabling us to
create what we believe to be the highest quality and most comprehensive research covering the
broadest range of sectors in the IT market. Our analysts regularly interact with technology
providers, CIOs and other leaders in the IT market in order to stay at the forefront of emerging IT
trends and deepen their understanding of our clients needs. Since our
1
inception in 1979, our analysts research has helped our clients increase productivity and
obtain higher levels of revenue and profitability by giving them the perspective and data to
improve key business processes, optimize IT investments, and capitalize on emerging technologies.
We employ a diversified business model that utilizes and leverages the breadth and depth of
our research intellectual capital. The foundation for our business model is our ability to create
and distribute our unique, proprietary research content as broadly as possible via:
|
|
|
published reports and briefings, |
|
|
|
|
consulting and advisory services, and |
|
|
|
|
hosting symposia, conferences and exhibitions. |
In early 2005, we undertook an initiative to better utilize the intellectual capital
associated with our core research product. Our business model provides multiple entry points and
synergies that facilitate increased client spending on our research, consulting and events. A
critical part of our long-term strategy is to increase business volume with our most valuable
clients, identifying relationships with the greatest sales potential and expanding those
relationships by offering strategically relevant research and analysis. We also seek to extend the
Gartner brand name to develop new client relationships, and augment our sales capacity and expand
into new markets around the world. In addition, we seek to increase our revenue and operating cash
flow through more effective pricing of our products and services. We believe these initiatives
will create additional revenue through more effective packaging, campaigning and cross-selling of
our products and services.
Corporate Information
We are incorporated under the laws of the State of Delaware. Our principal executive offices
are located at 56 Top Gallant Road, Stamford, Connecticut 06902. Our general telephone number is
203-316-1111. Our Internet address is www.gartner.com and the investor relations section of our
Web site is located at investor.gartner.com. The information on our website is not part of this
prospectus. For further information about our business, we refer you
to our Annual Reports on Form
10-K for the fiscal year ended December 31, 2005 and our
Quarterly Reports on Form 10-Q for the
fiscal quarters ended March 31, 2006 and June 30, 2006, which are incorporated into this prospectus
by reference. We make available free of charge, on or through the investor relations section of
our Web site, annual reports on Form 10-K, quarterly reports on Form 10-Q, current reports on Form
8-K and amendments to those reports filed or furnished pursuant to Section 13(a) or 15(d) of the
Securities Exchange Act of 1934 as soon as reasonably practicable after we electronically file such
material with, or furnish it to, the Securities and Exchange Commission.
The Offering
Under this prospectus, the selling stockholders may, from time to time, sell shares of our
common stock in one of more offerings. See the section of this prospectus entitled Plan of
Distribution beginning on page 11.
Selling Stockholders
ValueAct Capital Master Fund III, L.P. (VAC III), Mr. James C. Smith and the James C. Smith
and Norma I. Smith Foundation (the Smith Foundation) may, from time to time, sell shares of our
common stock in one or more offerings under this prospectus. VAC III is affiliated with our
director Jeffrey W. Ubben. Mr. Smith is the Chairman of our Board of Directors and a director of
the Smith Foundation. VAC III acquired the shares of common stock which are
being registered under this prospectus in a private transaction with Silver Lake Partners,
L.P., Silver Lake Investors, L.P., and Silver Lake Technology Investors, L.L.C.
(collectively, Silver Lake) on September 15, 2006. Mr. Smith acquired the
shares of common stock which are being registered under this
prospectus in a private transaction with Silver Lake on May 24,
2006. See Selling Stockholders for a
description of each of the selling stockholders.
2
RISK FACTORS
We operate in a very competitive and rapidly changing environment that involves numerous risks
and uncertainties, some of which are beyond our control. In addition, we and our clients are
affected by the economy. The following section discusses many, but not all, of these risks and
uncertainties.
Risks related to our business
Our operating results could be negatively impacted if the IT industry experiences an economic down
cycle.
Our revenues and results of operations are influenced by economic conditions in general and
more particularly by business conditions in the IT industry. A general economic downturn or
recession, anywhere in the world, could negatively affect demand for our products and services and
may substantially reduce existing and potential client information technology-related budgets.
Such a downturn could materially and adversely affect our business, financial condition and results
of operations, including the ability to: maintain client retention, wallet retention and consulting
utilization rates, and achieve contract value and consulting backlog.
We face significant competition and our failure to compete successfully could materially adversely
affect our results of operations and financial condition.
We face direct competition from a significant number of independent providers of information
products and services, including information that can be found on the Internet free of charge. We
also compete indirectly against consulting firms and other information providers, including
electronic and print media companies, some of which may have greater financial, information
gathering and marketing resources than we do. These indirect competitors could also choose to
compete directly with us in the future. In addition, limited barriers to entry exist in the
markets in which we do business. As a result, additional new competitors may emerge and existing
competitors may start to provide additional or complementary services. Additionally, technological
advances may provide increased competition from a variety of sources. However, we believe the
breadth and depth of our research assets position us well versus our competition. There can be no
assurance that we will be able to successfully compete against current and future competitors and
our failure to do so could result in loss of market share, diminished value in our products and
services, reduced pricing and increased marketing expenditures. Furthermore, we may not be
successful if we cannot compete effectively on quality of research and analysis, timely delivery of
information, customer service, and the ability to offer products to meet changing market needs for
information and analysis, or price.
We may not be able to maintain our existing products and services.
We operate in a rapidly evolving market, and our success depends upon our ability to deliver
high quality and timely research and analysis to our clients. Any failure to continue to provide
credible and reliable information that is useful to our clients could have a material adverse
effect on future business and operating results. Further, if our predictions prove to be wrong or
are not substantiated by appropriate research, our reputation may suffer and demand for our
products and services may decline. In addition, we must continue to improve our methods for
delivering our products and services in a cost-effective manner. Failure to increase and improve
our electronic delivery capabilities could adversely affect our future business and operating
results.
We may not be able to introduce the new products and services that we need to remain competitive.
The market for our products and services is characterized by rapidly changing needs for
information and analysis. To maintain our competitive position, we must continue to enhance and
improve our products
3
and services, develop or acquire new products and services in a timely manner, and
appropriately position and price new products and services relative to the marketplace and our
costs of producing them. Any failure to achieve successful client acceptance of new products and
services could have a material adverse effect on our business, results of operations or financial
position.
We depend on renewals of subscription based services and sales of new subscription based services
for a significant portion of our revenue, and our failure to renew at historical rates or generate
new sales of such services could lead to a decrease in our revenues.
A large portion of our success depends on our ability to generate renewals of our
subscription-based research products and services and new sales of such products and services, both
to new clients and existing clients. These products and services constituted 53% and 54% of our
revenues for 2005 and 2004, respectively, and 53% and 55% of our revenues for the first six months
of 2006 and 2005, respectively. If we are not able to renew at historical rates, and do not
generate new sales in an amount sufficient to account for the shortfall arising from a decrease in
renewals, our revenues will be negatively affected.
Our research subscription agreements have terms that generally range from twelve to thirty
months. Our ability to maintain contract renewals is subject to numerous factors, including the
following:
|
|
|
delivering high-quality and timely analysis and advice to our clients; |
|
|
|
|
understanding and anticipating market trends and the changing needs of our clients; and |
|
|
|
|
delivering products and services of the quality and timeliness necessary to
withstand competition. |
Additionally, as we implement our strategy to realign our business to client needs, we may
shift the type and pricing of our products which may impact client renewal rates. While research
client retention rates were 81% and 80% at December 31, 2005 and 2004, respectively, and 80% at
June 30, 2006 and 2005, respectively, there can be no guarantee that we will continue to maintain
this rate of client renewals.
Generating new sales of our subscription based products and services, both to new and existing
clients, is often a time consuming process. If we are unable to generate new sales, due to
competition or other factors, our revenues will be adversely affected.
We depend on non-recurring consulting engagements and our failure to secure new engagements could
lead to a decrease in our revenues.
Consulting segment revenues constituted 30% and 29% of our revenues for 2005 and 2004,
respectively, and 31% and 30% of our revenues for the first six months of 2006 and 2005,
respectively. These consulting engagements typically are project-based and non-recurring. Our
ability to replace consulting engagements is subject to numerous factors, including the following:
|
|
|
delivering consistent, high-quality consulting services to our clients; |
|
|
|
|
tailoring our consulting services to the changing needs of our clients; and |
|
|
|
|
our ability to match the skills and competencies of our consulting staff to the
skills required for the fulfillment of existing or potential consulting engagements. |
4
Any material decline in our ability to replace consulting arrangements could have an adverse
impact on our revenues and our financial condition.
The profitability and success of our conferences, symposia and events could be adversely affected
if we are unable to obtain desirable dates and locations.
The market for desirable dates and locations for conferences, symposia and events is highly
competitive. If we cannot secure desirable dates and locations for our conferences, symposia and
events their profitability could suffer, and our financial condition and results of operations may
be adversely affected. In addition, because our events are scheduled in advance and held at
specific locations, the success of these events can be affected by circumstances outside of our
control, such as labor strikes, transportation shutdowns, economic slowdowns, terrorist attacks,
natural disasters and other world events impacting the global economy, the occurrence of any of
which could negatively impact the success of the event.
We may not be able to attract and retain qualified personnel which could jeopardize the quality of
our products and services.
Our success depends heavily upon the quality of our senior management, research analysts,
consultants, sales and other key personnel. We face competition for the limited pool of these
qualified professionals from, among others, technology companies, market research firms, consulting
firms, financial services companies and electronic and print media companies, some of which have a
greater ability to attract and compensate these professionals. Some of the personnel that we
attempt to hire are subject to non-compete agreements that could impede our short-term recruitment
efforts. Any failure to retain key personnel or hire and train additional qualified personnel as
required to support the evolving needs of clients or growth in our business, could adversely affect
the quality of our products and services, and our future business and operating results.
We may not be able to maintain the equity in our brand name.
We believe that our Gartner brand, including our independence, is critical to our efforts to
attract and retain clients and that the importance of brand recognition will increase as
competition increases. We may expand our marketing activities to promote and strengthen the
Gartner brand and may need to increase our marketing budget, hire additional marketing and public
relations personnel, expend additional sums to protect the brand and otherwise increase
expenditures to create and maintain client brand loyalty. If we fail to effectively promote and
maintain the Gartner brand, or incur excessive expenses in doing so, our future business and
operating results could be materially and adversely impacted.
Our international operations expose us to a variety of risks which could negatively impact our
future revenue and growth.
Approximately 40% of our revenues for 2005 and 38% of our revenues for the first six months of
2006 were derived from sales outside of North America. As a result, our operating results are
subject to the risks inherent in international business activities, including general political and
economic conditions in each country, changes in foreign currency exchange rates, changes in market
demand as a result of tariffs and other trade barriers, challenges in staffing and managing foreign
operations, changes in regulatory requirements, compliance with numerous foreign laws and
regulations, different or overlapping tax structures, higher levels of United States taxation on
foreign income, and the difficulty of enforcing client agreements, collecting accounts receivable
and protecting intellectual property rights in international jurisdictions. Furthermore, we rely
on local distributors or sales agents in some international locations. If any of these
arrangements are terminated by our agent or us, we may not be able to replace the arrangement on
beneficial terms or on a timely basis, or clients of the local distributor or sales agent may not
want to continue to do business with us or our new agent.
5
The costs of servicing our outstanding debt obligations could impair our future operating results.
We have a $200.0 million term loan as well as a $125.0 million revolving credit facility. The
affirmative, negative and financial covenants of the credit facility could limit our future
financial flexibility. The associated debt service costs of these facilities could impair our
future operating results. The outstanding debt may limit the amount of cash or additional credit
available to us, which could restrain our ability to expand or enhance products and services,
respond to competitive pressures or pursue future business opportunities requiring substantial
investments of additional capital.
If we are unable to enforce and protect our intellectual property rights our competitive position
may be harmed.
We rely on a combination of copyright, patent, trademark, trade secret, confidentiality,
non-compete and other contractual provisions to protect our intellectual property rights. Despite
our efforts to protect our intellectual property rights, unauthorized third parties may obtain and
use technology or other information that we regard as proprietary. Our intellectual property
rights may not survive a legal challenge to their validity or provide significant protection for
us. The laws of certain countries do not protect our proprietary rights to the same extent as the
laws of the United States. Accordingly, we may not be able to protect our intellectual property
against unauthorized third-party copying or use, which could adversely affect our competitive
position. Our employees are subject to non-compete agreements. When the non-competition period
expires, former employees may compete against us. If a former employee chooses to compete against
us prior to the expiration of the non-competition period, there is no assurance that we will be
successful in our efforts to enforce the non-compete provision.
We have grown, and may continue to grow, through acquisitions and strategic investments, which
could involve substantial risks.
We have made and may continue to make acquisitions of, or significant investments in,
businesses that offer complementary products and services, including our acquisition of META that
we completed on April 1, 2005. The risks involved in each acquisition or investment include the
possibility of paying more than the value we derive from the acquisition, dilution of the interests
of our current stockholders or decreased working capital, increased indebtedness, the assumption of
undisclosed liabilities and unknown and unforeseen risks, the ability to retain key personnel of
the acquired company, the time to train the sales force to market and sell the products of the
acquired business, the potential disruption of our ongoing business and the distraction of
management from our business. The realization of any of these risks could adversely affect our
business.
We face risks related to litigation.
We are, and may in the future be, subject to a variety of legal actions, such as employment,
breach of contract, intellectual property-related, and business torts, including claims of unfair
trade practices and misappropriation of trade secrets. Given the nature of our business, we are
also subject to defamation (including libel and slander), negligence, or other claims relating to
the information we publish. Regardless of the merits, responding to any such claim could be time
consuming, result in costly litigation and require us to enter into settlements, royalty and
licensing agreements which may not be offered or available on reasonable terms. If a successful
claim is made against us and we fail to settle the claim on reasonable terms, our business, results
of operations or financial position could be materially adversely affected.
6
Risks related to our common stock
Our operating results may fluctuate from period to period and may not meet the expectations of
securities analysts or investors, which may cause the price of our common stock to decline.
Our quarterly and annual operating results may fluctuate in the future as a result of many
factors, including the timing of the execution of research contracts, which typically occurs in the
fourth calendar quarter, the extent of completion of consulting engagements, the timing of symposia
and other events, which also occur to a greater extent in the fourth calendar quarter, the amount
of new business generated, the mix of domestic and international business, changes in market demand
for our products and services, the timing of the development, introduction and marketing of new
products and services, and competition in the industry. An inability to generate sufficient
earnings and cash flow, and achieve our forecasts, may impact our operating and other activities.
The potential fluctuations in our operating results could cause period-to-period comparisons of
operating results not to be meaningful and may provide an unreliable indication of future operating
results. Furthermore, our operating results may not meet the expectations of securities analysts
or investors in the future. If this occurs, the price of our stock would likely decline.
Interests of certain of our significant stockholders may conflict with yours.
After
giving effect to the sale of 2,000,000 shares of our common stock by Silver Lake to VAC
III on September 15, 2006, Silver Lake owns
approximately 20.7% of our common stock. Silver Lake is restricted from
purchasing additional stock without our consent pursuant to the terms of a Securityholders
Agreement. This Securityholders Agreement also provides that we cannot take certain actions,
including acquisitions and sales of stock and/or assets without Silver Lakes consent.
Additionally, after giving effect to the purchase of the 2,000,000 shares of our common stock from
Silver Lake on September 15, 2006, VAC III, together
with its affiliate ValueAct Capital Master Fund, L.P. (VAC,
together with VAC III, ValueAct Capital), owns approximately 18.1% of our common stock,
including the 2,000,000 shares of common stock that may be offered for resale under this
prospectus. While neither Silver Lake nor ValueAct Capital, individually, holds a majority of our
outstanding shares, they may be able, either individually or together, to exercise significant
influence over matters requiring stockholder approval, including the election of directors and the
approval of mergers, consolidations and sales of our assets. Their interests may differ from the
interests of other stockholders. Additionally, representatives of Silver Lake and ValueAct Capital
in the aggregate presently hold three seats on our Board of Directors.
Our stock price may be volatile, and you may not be able to resell shares of our common stock at or
above the price you paid.
The trading prices of our common stock could be subject to significant fluctuations in
response to, among other factors, variations in operating results, developments in the industries
in which we do business, general economic conditions, changes in securities analysts
recommendations regarding our securities and our performance relative to securities analysts
expectations for any quarterly period. Such volatility may adversely affect the market price of
our common stock.
Future sales of our common stock in the public market could lower our stock price.
Sales of a substantial number of shares of common stock in the public market by our current
stockholders, or the threat that substantial sales may occur, could cause the market price of our
common stock to decrease significantly or make it difficult for us to raise additional capital by
selling stock. Furthermore, we have various equity incentive plans that provide for awards in the
form of stock options, stock appreciation rights, restricted stock, restricted stock units and
other stock based awards. As of August 31,
7
2006, the aggregate number of shares of our common stock issuable pursuant to outstanding
grants awarded under these plans was approximately 17.0 million shares (approximately 13.3 million
of which have vested). In addition, approximately 8.6 million shares may be issued in connection
with future awards under our equity incentive plans. Shares of common stock issued under these
plans are freely transferable without further registration under the Securities Act, except for any
shares held by an affiliate (as that term is defined in Rule 144 under the Securities Act). We
cannot predict the size of future issuances of our common stock or the effect, if any, that future
issuances and sales of shares of our common stock will have on the market price of our common
stock.
Our anti-takeover protections may discourage or prevent a change of control, even if a change in
control would be beneficial to our stockholders.
Provisions of our restated certificate of incorporation and bylaws and Delaware law may make
it difficult for any party to acquire control of us in a transaction not approved by our Board of
Directors. These provisions include:
|
|
|
the ability of our Board of Directors to issue and determine the terms of Preferred Stock; |
|
|
|
|
advance notice requirements for inclusion of stockholder proposals at stockholder meetings; |
|
|
|
|
a preferred shares rights agreement; and |
|
|
|
|
the anti-takeover provisions of Delaware law. |
These provisions could discourage or prevent a change of control or change in management that
might provide stockholders with a premium to the market price of their common stock.
8
USE OF PROCEEDS
We will not receive any proceeds from the sales of shares of common stock offered for sale in
this prospectus by the selling stockholders. The selling stockholders will receive all of the net
proceeds from these sales.
SELLING STOCKHOLDERS
We are registering for resale 2,200,000 shares of our common stock. The following table sets
forth the name of the selling stockholders, the number of shares and percentage of our common stock
beneficially owned by the selling stockholders as of August 31, 2006 (after giving effect to the
purchase of 2,000,000 shares of our common stock by VAC III from
Silver Lake on September 15, 2006), the number of shares
of common stock that may be offered for resale for the account of the selling stockholders under
this prospectus and the number and percentage of shares to be beneficially owned by the selling
stockholders after the offering of the resale shares (assuming all of the offered resale shares are
sold by the selling stockholders).
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Shares Beneficially Owned |
|
|
|
|
|
Shares Beneficially Owned |
|
|
Prior to Offering (1) |
|
Number of |
|
After this Offering (1) |
|
|
|
|
|
|
Percent of |
|
Shares |
|
|
|
|
|
Percent of |
Name of Beneficial Owner |
|
Number |
|
Class (2) |
|
Offered |
|
Number |
|
Class (2) |
ValueAct Capital (3)
435 Pacific Avenue, Fourth Floor
San Francisco, CA 94133 |
|
|
20,631,646 |
|
|
|
18.1 |
% |
|
|
2,000,000 |
|
|
|
18,631,646 |
|
|
|
16.3 |
% |
James C. Smith
c/o Gartner, Inc.
56 Top Gallant Road
Stamford, CT 06902 |
|
|
582,001 |
(4) |
|
|
|
* |
|
|
135,000 |
|
|
|
382,001 |
(5) |
|
|
|
* |
James C.
Smith and Norma I. Smith Foundation
c/o Gartner, Inc.
56 Top Gallant Road
Stamford, CT 06902 |
|
|
90,000 |
|
|
|
|
* |
|
|
65,000 |
|
|
|
25,000 |
|
|
|
|
* |
|
|
|
* |
|
Less than 1% |
|
(1) |
|
Beneficial ownership is a term broadly defined by the Securities and Exchange Commission in
Rule 13d-3 under the Securities Exchange Act of 1934, and includes more than the typical form
of stock ownership, that is, stock held in the persons name. The term also includes what is
referred to as indirect ownership, meaning ownership of shares as to which a person has or
shares investment power. As of any particular date, a person or group of persons is deemed to
have beneficial ownership of any shares underlying convertible securities beneficially held
by such person or group if the holder of such convertible securities has the right to convert
such convertible securities into common stock as of such date or within 60 days after such
date. |
|
(2) |
|
As required by SEC rules, for each person listed in the chart the percentages are calculated
assuming that all convertible securities beneficially held by such person are converted into
common stock to the extent possible and that no other convertible securities are converted
into common stock. Securities convertible into common stock include stock based awards
granted under Gartner stock incentive plans (such as options and restricted stock units). |
|
(3) |
|
Reported shares are owned directly by ValueAct Capital Master Fund III, L.P. (2,000,000
shares) and ValueAct Capital Master Fund, L.P. (18,631,646 shares) and may be deemed to be
beneficially owned by (i) VA Partners III, LLC as General Partner of ValueAct Capital Master
Fund III, L.P., (ii) VA Partners, LLC as General Partner of ValueAct Capital Master Fund,
L.P., (iii) ValueAct Capital Management, L.P. as the manager of ValueAct Capital Master Fund
III, L.P. and ValueAct Capital Master Fund, L.P. and (iv) ValueAct Capital Management, LLC as
General Partner of ValueAct Capital Management, L.P. All 2,000,000 shares of common stock
held by ValueAct |
9
|
|
|
|
|
Capital Master Fund III, L.P. are being registered for resale under this
prospectus. Following the sale of the
2,000,000 shares of common stock held by ValueAct Capital Master Fund III, L.P., it will not
directly own any shares of common stock of Gartner. None of the
18,631,646 shares held by ValueAct Capital
Master Fund, L.P. are being registered under this prospectus. Jeffrey W. Ubben is a director of Gartner,
Inc. and Managing Member of VA Partners, LLC, VA Partners III, LLC and ValueAct Capital
Management, LLC. Peter H. Kamin and George F. Hamel, Jr. are Managing Members of VA Partners,
LLC, VA Partners III, LLC and ValueAct Capital Management, LLC. The reporting persons disclaim
beneficial ownership of the reported stock except to the extent of their pecuniary interest
therein. |
|
(4) |
|
Includes 22,001 shares of common stock issuable upon the exercise of stock options that are
exercisable within 60 days of August 31, 2006, and 90,000 shares of common stock held by the
James C. Smith and Norma I. Smith Foundation (65,000 of which are being registered for resale
under this prospectus) and 10,000 shares of common stock held by a member of Mr. Smiths
immediate family as to which Mr. Smith may be deemed a beneficial owner. Mr. Smith is the
Chairman of Gartners Board of Directors. Mr. Smith is also a director of the James C. Smith
and Norma I. Smith Foundation. |
|
(5) |
|
Includes 22,001 shares of common stock issuable upon the exercise of stock options that are
exercisable within 60 days of August 31, 2006, and 25,000 shares of common stock held by the
James C. Smith and Norma I. Smith Foundation and 10,000 shares of common stock held by a
member of Mr. Smiths immediate family as to which Mr. Smith may be deemed a beneficial owner. |
10
PLAN OF DISTRIBUTION
The selling stockholders may sell the shares of common stock offered hereby at any time and
from time to time either
|
|
|
directly to one or more purchasers; or |
|
|
|
|
through underwriters, broker-dealers or agents who may receive compensation in
the form of discounts, concessions or commissions from the selling stockholders or
from purchasers of the shares of common stock. |
As used in this prospectus, the term selling stockholders includes donees, pledgees,
transferees or other successors-in-interest selling shares received from a named selling
stockholder as a gift or other non-sale related transfer after the date of this prospectus. The
selling stockholders will act independently of us in making decisions regarding the timing, manner
and size of each sale. Each selling stockholder reserves the right to accept and, together with
its agents from time to time, reject, in whole or in part any proposed purchase of the shares of
common stock to be made directly or through agents.
The selling stockholders and broker-dealers or agents, if any, who participate in the
distribution of the shares of common stock offered under this prospectus may be deemed to be
underwriters within the meaning of Section 2(a)(11) of the Securities Act of 1933. As a result,
any profits on the sale of the shares of common stock by selling stockholders and any discounts,
commissions or concessions received by any participating broker-dealers or agents might be deemed
to be underwriting discounts or commissions under the Securities Act of 1933. Selling stockholders
who are deemed to be underwriters may be subject to certain statutory liabilities, including, but
not limited to, those under Sections 11, 12 and 17 of the Securities Act of 1933 and Rule 10b-5
under the Securities Exchange Act of 1934. Because the selling stockholders may be deemed to be
underwriters within the meaning of the Securities Act, they will be subject to the prospectus
delivery requirements of the Securities Act. In addition, any securities covered by this
prospectus that qualify for resale pursuant to Rule 144 under the Securities Act may be sold under
Rule 144 rather than under this prospectus.
The shares of common stock offered hereby may be sold from time to time on any stock exchange
or automated interdealer quotation system on which such shares of common stock are listed, in the
over-the-counter market, in privately negotiated transactions or otherwise, at fixed prices that
may be changed, at market prices prevailing at the time of sale, at prices related to prevailing
market prices or at prices otherwise negotiated.
The selling stockholders may sell the shares of common stock by one or more of the following
methods, without limitation:
|
|
|
block trades in which the broker or dealer so engaged will attempt to sell the
shares of common stock as agent but may position and resell a portion of the block
as principal to facilitate the transaction; |
|
|
|
|
purchases by a broker or dealer as principal and resale by the broker or dealer
for its own account; |
|
|
|
|
ordinary brokerage transactions and transactions in which the broker solicits purchases; |
11
|
|
|
privately negotiated transactions; |
|
|
|
|
closing out of short sales; |
|
|
|
|
satisfying delivery obligations relating to the writing of options on the shares
of common stock, whether or not the options are listed on an options exchange; |
|
|
|
|
one or more underwritten offerings on a firm commitment or best efforts basis; |
|
|
|
|
any combination of any of these methods; or |
|
|
|
|
any other method permitted pursuant to applicable law. |
The selling stockholders may engage brokers and dealers, and any brokers or dealers may
arrange for other brokers or dealers to participate in effecting sales of the common stock. These
brokers, dealers or underwriters may act as principals, or as an agent of a selling stockholder.
Broker-dealers may agree with a selling stockholder to sell a specified number of the shares of
common stock at a stipulated price per security. If the broker-dealer is unable to sell the shares
of common stock as agent for a selling stockholder, it may purchase as principal any unsold shares
of common stock at the stipulated price. Broker-dealers who acquire shares of common stock as
principal may thereafter resell the shares of common stock from time to time in transactions in any
stock exchange or automated interdealer quotation system on which the shares of common stock are
then listed, at prices and on terms then prevailing at the time of sale, at prices related to the
then-current market price or in negotiated transactions. Broker-dealers may use block transactions
and sales to and through broker-dealers, including transactions of the nature described above.
A selling stockholder may enter into hedging transactions with broker-dealers and the
broker-dealers may engage in short sales of the shares of common stock in the course of hedging the
positions they assume with that selling stockholder, including without limitation, in connection
with distributions of the shares of common stock by those broker-dealers. A selling stockholder
may enter into option or other transactions with broker-dealers that involve the delivery of the
shares of common stock offered hereby to the broker-dealers, who may then resell or otherwise
transfer those shares of common stock. A selling stockholder may also loan or pledge the shares of
common stock offered hereby to a broker-dealer and the broker-dealer may sell shares of common
stock offered hereby so loaned or upon a default may sell or otherwise transfer the pledged shares
of common stock offered hereby.
To our knowledge, there are currently no plans, arrangements or understandings between any
selling stockholders and any underwriter, broker-dealer or agent regarding the sale of the shares
of common stock offered by this prospectus. Selling stockholders may decide not to sell any of the
shares of common stock offered under this prospectus, or they might decide to transfer the shares
of common stock by other means not described in this prospectus. Additionally, selling
stockholders may resell all or a portion of their shares of common stock in open market
transactions pursuant to Rule 144 under the Securities Act of 1933 rather than pursuant to this
prospectus, so long as they meet the applicable criteria and conform to the requirements of those
rules.
Under applicable rules and regulations under the Securities and Exchange Act of 1934, any
person engaged in the distribution of the shares may not simultaneously engage in market making
activities with respect to our common stock for a period of two business days prior to the
commencement of the distribution. In addition, the selling stockholders will be subject to
applicable provisions of the Exchange Act and the rules and regulations thereunder, including
Regulation M, which may limit the timing of purchases and sales of shares of our common stock by
the selling stockholders or any other person. This may affect the
12
marketability of the shares of
common stock as well as the ability of any person or entity to engage in market-making activities
with respect to the shares of common stock.
VAC III and Silver Lake will bear all costs, expenses and fees associated with the
registration of the shares. The selling stockholders will bear all fees and expenses, if any, of
counsel or other advisors to the selling stockholders and all commissions, brokerage fees and
discounts, if any, associated with the sale of the shares.
13
LEGAL MATTERS
The validity of the shares of common stock offered hereby will be passed upon for us by Wilson
Sonsini Goodrich & Rosati, Professional Corporation, Palo Alto, California.
EXPERTS
The consolidated financial statements of Gartner Inc. and its subsidiaries, as of December 31,
2005 and 2004, and for each of the years in the three-year period ended December 31, 2005, and
managements assessment of the effectiveness of internal control over financial reporting as of
December 31, 2005, have been incorporated by reference herein and in the registration statement in
reliance upon the reports of KPMG LLP, our independent registered public accounting firm,
incorporated by reference herein, and upon the authority of said firm as experts in accounting and
auditing.
AVAILABLE INFORMATION
We file annual, quarterly and current reports, proxy statements and other information with the
Securities and Exchange Commission, or SEC. You may read and copy any materials we file at the
SECs Public Reference Room at 100 F Street, N.E., Washington, D.C. 20549. You may obtain
information on the operation of the Public Reference Room by calling the SEC at 1-888-SEC-0330.
The SEC maintains a website at www.sec.gov that contains reports, proxy and information statements,
and other information regarding issuers that file electronically with the SEC. Our SEC filings are
also available to the public from our website at www.gartner.com. However, the information on our
website does not constitute a part of this prospectus.
In this document, we incorporate by reference certain information we file with the SEC,
which means that we can disclose important information to you by referring to that information.
The information incorporated by reference is considered to be a part of this prospectus. Any
statement contained in a document incorporated by reference herein shall be deemed to be modified
or superseded for all purposes to the extent that a statement contained in this prospectus or in
any other subsequently filed document that is also incorporated or deemed to be incorporated by
reference, modifies or supersedes such statement. Any statement so modified or superseded shall
not be deemed, except as so modified or superseded, to constitute a part of this prospectus. We
incorporate by reference the documents listed below:
|
|
|
our Annual Report on Form 10-K for the fiscal year ended December 31, 2005; |
|
|
|
|
our Quarterly Reports on Form 10-Q for the fiscal quarters ended March 31, 2006 and
June 30, 2006; |
|
|
|
|
our Current Reports on Form 8-K dated February 1, 2006; February 7, 2006 (Items 5.02
and 5.03 only); February 16, 2006; March 20, 2006;
May 9, 2006; May 19, 2006; and May 24,
2006; and |
|
|
|
|
the descriptions of our common stock contained in our
Registration Statement on Form 8-A dated July 6, 2005, including any amendment or report filed with the SEC for the
purpose of updating such description. |
All reports and other documents subsequently filed by us pursuant to Sections 13(a), 13(c), 14
and 15(d) of the Exchange Act (other than Current Reports furnished under Item 2.02 or Item 7.01
(including any financial statements or other exhibits relating thereto furnished pursuant to Item
9.01) of Form 8-K) after the
14
date of this prospectus and prior to the termination of this offering
shall be deemed to be incorporated by reference in this prospectus and to be part hereof from the
date of filing of such reports and other documents.
Gartner hereby undertakes to provide without charge to each person, including any beneficial
owner, to whom a copy of this prospectus is delivered, upon written or oral request of any such
person, a copy of any and all of the information that has been or may be incorporated by reference
in this prospectus, other than exhibits to such documents. Requests for such copies should be
directed to our Investor Relations department, at the following address:
Gartner, Inc.
56 Top Gallant Road
Stamford, CT 06902
(203) 316-1111
You should rely only upon the information provided in this prospectus or incorporated by
reference into this prospectus. We have not authorized anyone to provide you with different
information. You should not assume that the information in this prospectus, including any
information incorporated by reference, is accurate as of any date other than the date of this
prospectus.
15
PART II
INFORMATION NOT REQUIRED IN PROSPECTUS
Item 14. Other Expenses of Issuance and Distribution.
The following table sets forth fees and expenses payable, other than underwriting discounts
and commissions, in connection with the issuance and distribution of the securities being
registered hereby. All amounts set forth below are estimates.
|
|
|
|
|
|
|
Amount |
|
|
|
to be Paid |
|
SEC registration fee |
|
$ |
3,687 |
|
Legal fees and expenses |
|
|
25,000 |
|
Accounting fees and expenses |
|
|
6,000 |
|
Miscellaneous |
|
|
5,000 |
|
|
|
|
|
Total |
|
$ |
39,687 |
|
|
|
|
|
ValueAct
Capital Master Fund III, L.P. and Silver Lake will bear all of the
expenses listed above.
Item 15. Indemnification of Officers and Directors.
Section 145 of the Delaware General Corporation Law authorizes a court to award, or a
corporations board of directors to grant, indemnity to officers, directors and other corporate
agents in terms sufficiently broad to permit such indemnification under certain circumstances and
subject to certain limitations.
As permitted by Section 145 of the Delaware General Corporation Law, the registrants restated
certificate of incorporation includes a provision that eliminates the personal liability of its
directors for monetary damages for breach of their fiduciary duty as directors.
In addition, as permitted by Section 145 of the Delaware General Corporation Law, the bylaws
of the registrant provide that:
|
|
|
The registrant shall indemnify its directors and officers for serving the registrant
in those capacities or for serving other business enterprises at the registrants
request, to the fullest extent permitted by Delaware law. |
|
|
|
|
The registrant may, in its discretion, indemnify employees and agents in those
circumstances where indemnification is not required by law. |
|
|
|
|
The registrant is required to advance expenses, as incurred, to its directors and
officers in connection with defending a proceeding, except that such director or
officer shall undertake to repay such advances if it is ultimately determined that such
person is not entitled to indemnification. |
|
|
|
|
The registrant will not be obligated pursuant to the bylaws to indemnify a person
with respect to proceedings initiated by that person, except with respect to
proceedings authorized by the registrants Board of Directors or brought to enforce a
right to indemnification. |
II-1
|
|
|
The rights conferred in the bylaws are not exclusive, and the registrant is
authorized to enter into indemnification agreements with its directors, officers,
employees and agents and to obtain insurance to indemnify such persons. |
|
|
|
|
The registrant may not retroactively amend the bylaw provisions to reduce its
indemnification obligations to directors, officers, employees and agents. |
The registrants policy is to enter into separate indemnification agreements with each of its
directors and executive officers that provide the maximum indemnity allowed to directors and
executive officers by Section 145 of the Delaware General Corporation Law and that allow for
certain additional procedural protections. The registrant also maintains directors and officers
insurance to insure such persons against certain liabilities.
These indemnification provisions and the indemnification agreements entered into between the
registrant and its officers and directors may be sufficiently broad to permit indemnification of
the registrants officers and directors for liabilities (including reimbursement of expenses
incurred) arising under the Securities Act.
Item 16. Exhibits and Financial Statement Schedules.
The following exhibits are included herein or incorporated herein by reference:
EXHIBIT INDEX
|
|
|
|
|
|
|
|
|
|
|
Incorporated by |
Exhibit |
|
|
|
reference herein |
Number |
|
Description |
|
From |
|
Date |
|
|
|
|
|
|
|
4.01
|
|
Form of Certificate for Common Stock
|
|
Form 8-K
|
|
July 6, 2005 |
|
|
|
|
|
|
|
4.02
|
|
Amended and Restated Rights
Agreement, dated as of August 31,
2002, between the Company and
Mellon Investor Services LLC (as
successor Rights Agent of Fleet
National Bank)
|
|
Form 10-K
|
|
December 27, 2002 |
|
|
|
|
|
|
|
4.03
|
|
Amendment No. 1 to the Amended and
Restated Rights Agreement, dated as
of August 31, 2002, by and between
the Company and Mellon Investor
Services LLC (as successor Rights
Agent of Fleet National Bank),
dated June 30, 2003, by and between
the Company and Mellon Investor
Services LLC
|
|
Form 8-A
|
|
June 30, 2003 |
|
|
|
|
|
|
|
4.04
|
|
Amended and Restated Credit
Agreement, dated as of June 29,
2005, to the Credit Agreement,
dated as of August 12, 2004, among
the Company, the several lenders
from time to time parties, and
JPMorgan Chase Bank, N.A. as
administrative agent (the Credit
Agreement)
|
|
Form 8-K
|
|
July 6, 2005 |
II-2
|
|
|
|
|
|
|
|
|
|
|
Incorporated by |
Exhibit |
|
|
|
reference herein |
Number |
|
Description |
|
From |
|
Date |
|
|
|
|
|
|
|
4.05
|
|
First Amendment to the Amended and
Restated Credit Agreement, dated as
of June 29, 2005, to the Credit
Agreement, dated as of August 12,
2004, among the Company, the
several lenders from time to time
who are parties, and JPMorgan Chase
Bank, N.A. as administrative agent
|
|
Form 8-K
|
|
February 16, 2006 |
|
|
|
|
|
|
|
5.01
|
|
Opinion of Wilson Sonsini Goodrich
& Rosati, Professional Corporation |
|
|
|
|
|
|
|
|
|
|
|
23.01
|
|
Consent of KPMG LLP, Independent
Registered Public Accounting Firm |
|
|
|
|
|
|
|
|
|
|
|
23.02
|
|
Consent of Wilson Sonsini Goodrich
& Rosati, Professional Corporation
(included in Exhibit 5.01 to this
Registration Statement) |
|
|
|
|
|
|
|
|
|
|
|
24.01
|
|
Power of Attorney (included on the
signature page of this Registration
Statement) |
|
|
|
|
Item 17. Undertakings.
(a) The undersigned Registrant hereby undertakes:
(1) To file, during any period in which offers or sales are being made, a post-effective
amendment to this registration statement:
(i) To include any prospectus required by section 10(a)(3) of the Securities Act of 1933;
(ii) To reflect in the prospectus any facts or events arising after the effective date of
the registration statement (or the most recent post-effective amendment thereof) which,
individually or in the aggregate, represent a fundamental change in the information set forth
in this registration statement. Notwithstanding the foregoing, any increase or decrease in
volume of securities offered (if the total dollar value of securities offered would not exceed
that which was registered) and any deviation from the low or high end of the estimated maximum
offering range may be reflected in the form of prospectus filed with the Commission pursuant
to Rule 424(b) if, in the aggregate, the changes in volume and price represent no more than a
20 percent change in the maximum aggregate offering price set forth in the Calculation of
Registration Fee table in the effective registration statement; and
(iii) To include any material information with respect to the plan of distribution not
previously disclosed in this registration statement or any material change to such information
in this registration statement;
provided, however, that paragraphs (a)(1)(i), (a)(1)(ii) and (a)(1)(iii) do not apply if
the information required to be included in a post-effective amendment by those paragraphs is
contained in reports filed with or furnished to the Securities and Exchange Commission by the
Registrant pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 that
are incorporated by reference in the registration statement, or is contained in a form of
prospectus filed pursuant to Rule 424(b) that is part of the registration statement.
II-3
(2) That, for the purpose of determining any liability under the Securities Act of 1933, each
such post-effective amendment shall be deemed to be a new registration statement relating to the
securities offered therein, and the offering of such securities at that time shall be deemed to be
the initial bona fide offering thereof.
(3) To remove from registration by means of a post-effective amendment any of the securities
being registered which remain unsold at the termination of the offering.
(5) That for the purpose of determining liability under the Securities Act of 1933 to any
purchaser:
(A) Each prospectus filed by the registrant pursuant to Rule 424(b)(3) shall be deemed to
be part of the registration statement as of the date the filed prospectus was deemed part of
and included in the registration statement; and
(B) Each prospectus required to be filed pursuant to Rule 424(b)(2), 424(b)(5), or
424(b)(7) as part of a registration statement in reliance on Rule 430B relating to an offering
made pursuant to Rule 415(a)(1)(i), 415(a)(1)(vii), or 415(a)(1)(x) for the purpose of
providing the information required by Section 10(a) of the Securities Act of 1933 shall be
deemed to be part of and included in the registration statement as of the earlier of the date
such form of prospectus is first used after effectiveness or the date of the first contract of
sale of the securities in the offering described in the prospectus. As provided in Rule 430B,
for liability purposes of the issuer and any person that is at that date an underwriter, such
date shall be deemed to be a new effective date of the registration statement relating to the
securities in the registration statement to which that prospectus relates, and the offering of
such securities at that time shall be deemed to be the initial bona fide offering thereof.
Provided, however, that no statement made in a registration statement or prospectus that is
part of the registration statement or made in a document incorporated or deemed incorporated
by reference into the registration statement or prospectus that is part of the registration
statement will, as to a purchaser with a time of contract of sale prior to such effective
date, supersede or modify any statement that was made in the registration statement or
prospectus that was part of the registration statement or made in any such document
immediately prior to such effective date.
(6) That, for the purposes of determining liability of the Registrant under the Securities Act
of 1933 to any purchaser in the initial distribution of the securities, the undersigned Registrant
undertakes that in a primary offering of securities of the undersigned Registrant pursuant to this
registration statement, regardless of the underwriting method used to sell the securities to the
purchaser, if the securities are offered or sold to such purchaser by means of any of the following
communications, the undersigned Registrant will be a seller to the purchaser and will be considered
to offer or sell such securities to such purchaser:
(i) Any preliminary prospectus or prospectus of the undersigned Registrant relating to the
offering required to be filed pursuant to Rule 424;
(ii) Any free writing prospectus relating to the offering prepared by or on behalf of the
undersigned Registrant or used or referred to by the undersigned Registrant;
(iii) The portion of any other free writing prospectus relating to the offering containing
material information about the undersigned Registrant or its securities provided by or on behalf of
the undersigned Registrant; and
(iv) Any other communication that is an offer in the offering made by the undersigned
Registrant to the purchaser.
(b) That, for purposes of determining any liability under the Securities Act of 1933, each filing
of the Registrants annual report pursuant to Section 13(a) or Section 15(d) of the Securities
Exchange Act of 1934 (and, where applicable, each filing of an employee benefit plans annual
report pursuant to Section 15(d) of
II-4
the Securities Exchange Act of 1934) that is incorporated by reference in the registration
statement shall be deemed to be a new registration statement relating to the securities offered
therein, and the offering of such securities at that time shall be deemed to be the initial bona
fide offering thereof.
(h) Insofar as indemnification for liabilities arising under the Securities Act of 1933 may be
permitted to directors, officers and controlling persons of the Registrant pursuant to the
provisions described under Item 15 of this registration statement, or otherwise, the Registrant has
been advised that in the opinion of the Securities and Exchange Commission such indemnification is
against public policy as expressed in the Securities Act of 1933 and is, therefore, unenforceable.
In the event that a claim for indemnification against such liabilities (other than the payment by
the Registrant of expenses incurred or paid by a director, officer or controlling person of the
Registrant in the successful defense of any action, suit or proceeding) is asserted by such
director, officer or controlling person in connection with the securities being registered, the
Registrant will, unless in the opinion of its counsel the matter has been settled by controlling
precedent, submit to a court of appropriate jurisdiction the question whether such indemnification
by it is against public policy as expressed in the Securities Act of 1933 and will be governed by
the final adjudication of such issue.
II-5
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the registrant certifies that it
has reasonable grounds to believe that it meets all of the requirements for filing on Form S-3 and
has duly caused this registration statement to be signed on its behalf by the undersigned,
thereunto duly authorized, in the City of Stamford, State of
Connecticut, on 18th day of
September, 2006.
|
|
|
|
|
|
GARTNER, INC.
|
|
|
By: |
/s/
Eugene A. Hall |
|
|
|
Eugene A. Hall |
|
|
|
Chief Executive Officer |
|
|
POWER OF ATTORNEY
KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below hereby
constitutes and appoints Eugene A. Hall and Christopher Lafond, and each of them acting
individually, as his true and lawful attorneys-in-fact and agents, each with full power of
substitution, for him in any and all capacities, to sign any and all amendments to this
registration statement (including post-effective amendments), and to file the same, with all
exhibits thereto and other documents in connection therewith, with the Securities and Exchange
Commission, granting unto said attorneys-in-fact and agents, with full power of each to act alone,
full power and authority to do and perform each and every act and thing requisite and necessary to
be done in connection therewith, as fully for all intents and purposes as he might or could do in
person, hereby ratifying and confirming all that said attorneys-in-fact and agents, or his or their
substitute or substitutes, may lawfully do or cause to be done by virtue hereof.
Pursuant to the requirements of the Securities Act of 1933, this registration statement on
Form S-3 has been signed by the following persons in the capacities and on the dates indicated:
|
|
|
|
|
Signature |
|
Title |
|
Date |
|
|
|
|
|
/s/
Eugene A. Hall
|
|
Director and Chief Executive Officer |
|
|
|
|
(Principal
Executive Officer)
|
|
September 18, 2006 |
|
|
|
|
|
/s/
Christopher Lafond
|
|
Chief Financial Officer (Principal |
|
|
|
|
Financial
and Accounting Officer)
|
|
September 18, 2006 |
|
|
|
|
|
/s/
Michael J. Bingle
|
|
Director
|
|
September 18, 2006 |
|
|
|
|
|
|
|
|
|
|
/s/
Richard J. Bressler
|
|
Director
|
|
September 18, 2006 |
|
|
|
|
|
|
|
|
|
|
/s/
Anne Sutherland Fuchs
|
|
Director
|
|
September 18, 2006 |
|
|
|
|
|
|
|
|
|
|
/s/
William O. Grabe
|
|
Director
|
|
September 18, 2006 |
|
|
|
|
|
|
|
|
|
|
Signature |
|
Title |
|
Date |
|
|
|
|
|
/s/
Max D. Hopper
|
|
Director
|
|
September 18, 2006 |
|
|
|
|
|
|
|
|
|
|
/s/
John R. Joyce
|
|
Director
|
|
September 18, 2006 |
|
|
|
|
|
|
|
|
|
|
/s/
Stephen J. Pagliuca
|
|
Director
|
|
September 18, 2006 |
|
|
|
|
|
|
|
|
|
|
/s/
James C. Smith
|
|
Director
|
|
September 18, 2006 |
|
|
|
|
|
|
|
|
|
|
/s/
Jeffrey W. Ubben
|
|
Director
|
|
September 18, 2006 |
|
|
|
|
|
|
|
|
|
|
/s/
Maynard G. Webb, Jr.
|
|
Director
|
|
September 18, 2006 |
|
|
|
|
|
EXHIBIT INDEX
|
|
|
|
|
|
|
|
|
|
|
Incorporated by |
Exhibit |
|
|
|
reference herein |
Number |
|
Description |
|
From |
|
Date |
|
|
|
|
|
|
|
4.01
|
|
Form of Certificate for Common Stock
|
|
Form 8-K
|
|
July 6, 2005 |
|
|
|
|
|
|
|
4.02
|
|
Amended and Restated Rights
Agreement, dated as of August 31,
2002, between the Company and
Mellon Investor Services LLC (as
successor Rights Agent of Fleet
National Bank)
|
|
Form 10-K
|
|
December 27, 2002 |
|
|
|
|
|
|
|
4.03
|
|
Amendment No. 1 to the Amended and
Restated Rights Agreement, dated as
of August 31, 2002, by and between
the Company and Mellon Investor
Services LLC (as successor Rights
Agent of Fleet National Bank),
dated June 30, 2003, by and between
the Company and Mellon Investor
Services LLC
|
|
Form 8-A
|
|
June 30, 2003 |
|
|
|
|
|
|
|
4.04
|
|
Amended and Restated Credit
Agreement, dated as of June 29,
2005, to the Credit Agreement,
dated as of August 12, 2004, among
the Company, the several lenders
from time to time parties, and
JPMorgan Chase Bank, N.A. as
administrative agent (the Credit
Agreement)
|
|
Form 8-K
|
|
July 6, 2005 |
|
|
|
|
|
|
|
4.05
|
|
First Amendment to the Amended and
Restated Credit Agreement, dated as
of June 29, 2005, to the Credit
Agreement, dated as of August 12,
2004, among the Company, the
several lenders from time to time
who are parties, and JPMorgan Chase
Bank, N.A. as administrative agent
|
|
Form 8-K
|
|
February 16, 2006 |
|
|
|
|
|
|
|
5.01
|
|
Opinion of Wilson Sonsini Goodrich
& Rosati, Professional Corporation |
|
|
|
|
|
|
|
|
|
|
|
23.01
|
|
Consent of KPMG LLP, Independent
Registered Public Accounting Firm |
|
|
|
|
|
|
|
|
|
|
|
23.02
|
|
Consent of Wilson Sonsini Goodrich
& Rosati, Professional Corporation
(included in Exhibit 5.01 to this
Registration Statement) |
|
|
|
|
|
|
|
|
|
|
|
24.01
|
|
Power of Attorney (included on the
signature page of this Registration
Statement) |
|
|
|
|